Moorthy VS - Search Results

1

Decision-making on malaria vaccine introduction: the role of cost-effectiveness analyses.

Moorthy VS, Hutubessy R, Newman RD, Hombach J. Moorthy VS, et al. Bull World Health Organ. 2012 Nov 1;90(11):864-6. doi: 10.2471/BLT.12.107482. Epub 2012 Sep 19. Bull World Health Organ. 2012. PMID: 23226899 Free PMC article. No abstract available.

2

Malaria vaccine technology roadmap.

Moorthy VS, Newman RD, Okwo-Bele JM. Moorthy VS, et al. Lancet. 2013 Nov 23;382(9906):1700-1. doi: 10.1016/S0140-6736(13)62238-2. Epub 2013 Nov 14. Lancet. 2013. PMID: 24239252 No abstract available.

3

Results from evaluations of models and cost-effectiveness tools to support introduction decisions for new vaccines need critical appraisal.

Hutubessy R, Henao AM, Namgyal P, Moorthy V, Hombach J. Hutubessy R, et al. BMC Med. 2011 May 12;9:55. doi: 10.1186/1741-7015-9-55. BMC Med. 2011. PMID: 21569407 Free PMC article.

4

Assessment of the RTS,S/AS01 malaria vaccine.

Moorthy VS, Newman RD, Duclos P, Okwo-Bele JM, Smith PG. Moorthy VS, et al. Lancet Infect Dis. 2013 Apr;13(4):280-2. doi: 10.1016/S1473-3099(13)70047-1. Epub 2013 Mar 1. Lancet Infect Dis. 2013. PMID: 23454165 No abstract available.

5

Developing a vaccine against Zika.

Hombach J, Friede M, Moorthy V, Costello A, Kieny MP. Hombach J, et al. BMJ. 2016 Nov 10;355:i5923. doi: 10.1136/bmj.i5923. BMJ. 2016. PMID: 27834272 Free PMC article.

6

Respiratory syncytial virus vaccine research and development: World Health Organization technological roadmap and preferred product characteristics.

Vekemans J, Moorthy V, Giersing B, Friede M, Hombach J, Arora N, Modjarrad K, Smith PG, Karron R, Graham B, Kaslow DC. Vekemans J, et al. Vaccine. 2019 Nov 28;37(50):7394-7395. doi: 10.1016/j.vaccine.2017.09.092. Epub 2018 Feb 1. Vaccine. 2019. PMID: 29395536 Review.

7

Final results from a pivotal phase 3 malaria vaccine trial.

Moorthy VS, Okwo-Bele JM. Moorthy VS, et al. Lancet. 2015 Jul 4;386(9988):5-7. doi: 10.1016/S0140-6736(15)60767-X. Epub 2015 Apr 23. Lancet. 2015. PMID: 25913271 No abstract available.

8

A review of malaria vaccine clinical projects based on the WHO rainbow table.

Schwartz L, Brown GV, Genton B, Moorthy VS. Schwartz L, et al. Among authors: moorthy vs. Malar J. 2012 Jan 9;11:11. doi: 10.1186/1475-2875-11-11. Malar J. 2012. PMID: 22230255 Free PMC article. Review.

9

A vaccine against malaria: a substantial step forward.

Moorthy V, Smith PG, Kieny MP. Moorthy V, et al. Lancet. 2009 Apr 25;373(9673):1411-2. doi: 10.1016/S0140-6736(09)60802-3. Lancet. 2009. PMID: 19394521 No abstract available.

10

Reducing empiricism in malaria vaccine design.

Moorthy VS, Kieny MP. Moorthy VS, et al. Lancet Infect Dis. 2010 Mar;10(3):204-11. doi: 10.1016/S1473-3099(09)70329-9. Lancet Infect Dis. 2010. PMID: 20185099 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters